Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.

Identifieur interne : 000A25 ( Main/Exploration ); précédent : 000A24; suivant : 000A26

Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.

Auteurs : Eleni Chantzoura [Grèce] ; Efthimios Prinarakis ; Dimitris Panagopoulos ; George Mosialos ; Giannis Spyrou

Source :

RBID : pubmed:21078302

Descripteurs français

English descriptors

Abstract

Glutaredoxin-1 (GRX-1) is a cytoplasmic enzyme that highly contributes to the antioxidant defense system. It catalyzes the reversible reduction of glutathione-protein mixed disulfides, a process called deglutathionylation. Here, we investigated the role of GRX-1 in the pathway triggered by interleukin-1/Toll-like receptor 4 (IL-1R/TLR4) by using RNA interference (RNAi) in HEK293 and HeLa cells. TNF receptor-associated factor 6 (TRAF6) is an intermediate signalling molecule involved in the signal transduction by members of the interleukin-1/Toll-like receptor (IL-1R/TLR) family. TRAF6 has an E3 ubiquitin ligase activity which depends on the integrity of an amino-terminal really interesting new gene (RING) finger motif. Upon receptor activation, TRAF6 undergoes K63-linked auto-polyubiquitination which mediates protein-protein interactions and signal propagation. Our data showed that IL-1R and TLR4-mediated NF-κB induction was severely reduced in GRX-1 knockdown cells. We found that the RING-finger motif of TRAF6 is S-glutathionylated under normal conditions. Moreover, upon IL-1 stimulation TRAF6 undergoes deglutathionylation catalyzed by GRX-1. The deglutathionylation of TRAF6 is essential for its auto-polyubiquitination and subsequent activation. Taken together, our findings reveal another signalling molecule affected by S-glutathionylation and uncover a crucial role for GRX-1 in the TRAF6-dependent activation of NF-κB by IL-1R/TLRs.

DOI: 10.1016/j.bbrc.2010.11.029
PubMed: 21078302


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.</title>
<author>
<name sortKey="Chantzoura, Eleni" sort="Chantzoura, Eleni" uniqKey="Chantzoura E" first="Eleni" last="Chantzoura">Eleni Chantzoura</name>
<affiliation wicri:level="1">
<nlm:affiliation>Center of Basic Research I, Biochemistry Division, Biomedical Research Foundation, Academy of Athens, 4 Soranou Efesiou Street, Athens 11527, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Center of Basic Research I, Biochemistry Division, Biomedical Research Foundation, Academy of Athens, 4 Soranou Efesiou Street, Athens 11527</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Prinarakis, Efthimios" sort="Prinarakis, Efthimios" uniqKey="Prinarakis E" first="Efthimios" last="Prinarakis">Efthimios Prinarakis</name>
</author>
<author>
<name sortKey="Panagopoulos, Dimitris" sort="Panagopoulos, Dimitris" uniqKey="Panagopoulos D" first="Dimitris" last="Panagopoulos">Dimitris Panagopoulos</name>
</author>
<author>
<name sortKey="Mosialos, George" sort="Mosialos, George" uniqKey="Mosialos G" first="George" last="Mosialos">George Mosialos</name>
</author>
<author>
<name sortKey="Spyrou, Giannis" sort="Spyrou, Giannis" uniqKey="Spyrou G" first="Giannis" last="Spyrou">Giannis Spyrou</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:21078302</idno>
<idno type="pmid">21078302</idno>
<idno type="doi">10.1016/j.bbrc.2010.11.029</idno>
<idno type="wicri:Area/Main/Corpus">000957</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000957</idno>
<idno type="wicri:Area/Main/Curation">000957</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000957</idno>
<idno type="wicri:Area/Main/Exploration">000957</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.</title>
<author>
<name sortKey="Chantzoura, Eleni" sort="Chantzoura, Eleni" uniqKey="Chantzoura E" first="Eleni" last="Chantzoura">Eleni Chantzoura</name>
<affiliation wicri:level="1">
<nlm:affiliation>Center of Basic Research I, Biochemistry Division, Biomedical Research Foundation, Academy of Athens, 4 Soranou Efesiou Street, Athens 11527, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Center of Basic Research I, Biochemistry Division, Biomedical Research Foundation, Academy of Athens, 4 Soranou Efesiou Street, Athens 11527</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Prinarakis, Efthimios" sort="Prinarakis, Efthimios" uniqKey="Prinarakis E" first="Efthimios" last="Prinarakis">Efthimios Prinarakis</name>
</author>
<author>
<name sortKey="Panagopoulos, Dimitris" sort="Panagopoulos, Dimitris" uniqKey="Panagopoulos D" first="Dimitris" last="Panagopoulos">Dimitris Panagopoulos</name>
</author>
<author>
<name sortKey="Mosialos, George" sort="Mosialos, George" uniqKey="Mosialos G" first="George" last="Mosialos">George Mosialos</name>
</author>
<author>
<name sortKey="Spyrou, Giannis" sort="Spyrou, Giannis" uniqKey="Spyrou G" first="Giannis" last="Spyrou">Giannis Spyrou</name>
</author>
</analytic>
<series>
<title level="j">Biochemical and biophysical research communications</title>
<idno type="eISSN">1090-2104</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Glutaredoxins (metabolism)</term>
<term>Glutathione (metabolism)</term>
<term>HEK293 Cells (MeSH)</term>
<term>HeLa Cells (MeSH)</term>
<term>Humans (MeSH)</term>
<term>NF-kappa B (metabolism)</term>
<term>Protein Processing, Post-Translational (MeSH)</term>
<term>RING Finger Domains (MeSH)</term>
<term>Receptors, Interleukin-1 (metabolism)</term>
<term>Signal Transduction (MeSH)</term>
<term>TNF Receptor-Associated Factor 6 (metabolism)</term>
<term>Toll-Like Receptor 4 (metabolism)</term>
<term>Ubiquitination (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cellules HEK293 (MeSH)</term>
<term>Cellules HeLa (MeSH)</term>
<term>Domaines à doigts de zinc de type RING (MeSH)</term>
<term>Facteur de transcription NF-kappa B (métabolisme)</term>
<term>Facteur-6 associé aux récepteurs de TNF (métabolisme)</term>
<term>Glutarédoxines (métabolisme)</term>
<term>Glutathion (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Maturation post-traductionnelle des protéines (MeSH)</term>
<term>Récepteur de type Toll-4 (métabolisme)</term>
<term>Récepteurs à l'interleukine-1 (métabolisme)</term>
<term>Transduction du signal (MeSH)</term>
<term>Ubiquitination (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Glutaredoxins</term>
<term>Glutathione</term>
<term>NF-kappa B</term>
<term>Receptors, Interleukin-1</term>
<term>TNF Receptor-Associated Factor 6</term>
<term>Toll-Like Receptor 4</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Facteur de transcription NF-kappa B</term>
<term>Facteur-6 associé aux récepteurs de TNF</term>
<term>Glutarédoxines</term>
<term>Glutathion</term>
<term>Récepteur de type Toll-4</term>
<term>Récepteurs à l'interleukine-1</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>HEK293 Cells</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Protein Processing, Post-Translational</term>
<term>RING Finger Domains</term>
<term>Signal Transduction</term>
<term>Ubiquitination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cellules HEK293</term>
<term>Cellules HeLa</term>
<term>Domaines à doigts de zinc de type RING</term>
<term>Humains</term>
<term>Maturation post-traductionnelle des protéines</term>
<term>Transduction du signal</term>
<term>Ubiquitination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Glutaredoxin-1 (GRX-1) is a cytoplasmic enzyme that highly contributes to the antioxidant defense system. It catalyzes the reversible reduction of glutathione-protein mixed disulfides, a process called deglutathionylation. Here, we investigated the role of GRX-1 in the pathway triggered by interleukin-1/Toll-like receptor 4 (IL-1R/TLR4) by using RNA interference (RNAi) in HEK293 and HeLa cells. TNF receptor-associated factor 6 (TRAF6) is an intermediate signalling molecule involved in the signal transduction by members of the interleukin-1/Toll-like receptor (IL-1R/TLR) family. TRAF6 has an E3 ubiquitin ligase activity which depends on the integrity of an amino-terminal really interesting new gene (RING) finger motif. Upon receptor activation, TRAF6 undergoes K63-linked auto-polyubiquitination which mediates protein-protein interactions and signal propagation. Our data showed that IL-1R and TLR4-mediated NF-κB induction was severely reduced in GRX-1 knockdown cells. We found that the RING-finger motif of TRAF6 is S-glutathionylated under normal conditions. Moreover, upon IL-1 stimulation TRAF6 undergoes deglutathionylation catalyzed by GRX-1. The deglutathionylation of TRAF6 is essential for its auto-polyubiquitination and subsequent activation. Taken together, our findings reveal another signalling molecule affected by S-glutathionylation and uncover a crucial role for GRX-1 in the TRAF6-dependent activation of NF-κB by IL-1R/TLRs.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21078302</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>01</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1090-2104</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>403</Volume>
<Issue>3-4</Issue>
<PubDate>
<Year>2010</Year>
<Month>Dec</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>Biochemical and biophysical research communications</Title>
<ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.</ArticleTitle>
<Pagination>
<MedlinePgn>335-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2010.11.029</ELocationID>
<Abstract>
<AbstractText>Glutaredoxin-1 (GRX-1) is a cytoplasmic enzyme that highly contributes to the antioxidant defense system. It catalyzes the reversible reduction of glutathione-protein mixed disulfides, a process called deglutathionylation. Here, we investigated the role of GRX-1 in the pathway triggered by interleukin-1/Toll-like receptor 4 (IL-1R/TLR4) by using RNA interference (RNAi) in HEK293 and HeLa cells. TNF receptor-associated factor 6 (TRAF6) is an intermediate signalling molecule involved in the signal transduction by members of the interleukin-1/Toll-like receptor (IL-1R/TLR) family. TRAF6 has an E3 ubiquitin ligase activity which depends on the integrity of an amino-terminal really interesting new gene (RING) finger motif. Upon receptor activation, TRAF6 undergoes K63-linked auto-polyubiquitination which mediates protein-protein interactions and signal propagation. Our data showed that IL-1R and TLR4-mediated NF-κB induction was severely reduced in GRX-1 knockdown cells. We found that the RING-finger motif of TRAF6 is S-glutathionylated under normal conditions. Moreover, upon IL-1 stimulation TRAF6 undergoes deglutathionylation catalyzed by GRX-1. The deglutathionylation of TRAF6 is essential for its auto-polyubiquitination and subsequent activation. Taken together, our findings reveal another signalling molecule affected by S-glutathionylation and uncover a crucial role for GRX-1 in the TRAF6-dependent activation of NF-κB by IL-1R/TLRs.</AbstractText>
<CopyrightInformation>Copyright © 2010 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Chantzoura</LastName>
<ForeName>Eleni</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Center of Basic Research I, Biochemistry Division, Biomedical Research Foundation, Academy of Athens, 4 Soranou Efesiou Street, Athens 11527, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Prinarakis</LastName>
<ForeName>Efthimios</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Panagopoulos</LastName>
<ForeName>Dimitris</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mosialos</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Spyrou</LastName>
<ForeName>Giannis</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Biochem Biophys Res Commun</MedlineTA>
<NlmUniqueID>0372516</NlmUniqueID>
<ISSNLinking>0006-291X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017472">Receptors, Interleukin-1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C495345">TLR4 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D048029">TNF Receptor-Associated Factor 6</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054829" MajorTopicYN="N">RING Finger Domains</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017472" MajorTopicYN="N">Receptors, Interleukin-1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D048029" MajorTopicYN="N">TNF Receptor-Associated Factor 6</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>11</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2010</Year>
<Month>11</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21078302</ArticleId>
<ArticleId IdType="pii">S0006-291X(10)02077-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.bbrc.2010.11.029</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Grèce</li>
</country>
<region>
<li>Attique (région)</li>
</region>
<settlement>
<li>Athènes</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Mosialos, George" sort="Mosialos, George" uniqKey="Mosialos G" first="George" last="Mosialos">George Mosialos</name>
<name sortKey="Panagopoulos, Dimitris" sort="Panagopoulos, Dimitris" uniqKey="Panagopoulos D" first="Dimitris" last="Panagopoulos">Dimitris Panagopoulos</name>
<name sortKey="Prinarakis, Efthimios" sort="Prinarakis, Efthimios" uniqKey="Prinarakis E" first="Efthimios" last="Prinarakis">Efthimios Prinarakis</name>
<name sortKey="Spyrou, Giannis" sort="Spyrou, Giannis" uniqKey="Spyrou G" first="Giannis" last="Spyrou">Giannis Spyrou</name>
</noCountry>
<country name="Grèce">
<region name="Attique (région)">
<name sortKey="Chantzoura, Eleni" sort="Chantzoura, Eleni" uniqKey="Chantzoura E" first="Eleni" last="Chantzoura">Eleni Chantzoura</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A25 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21078302
   |texte=   Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21078302" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020